文献速递心律失常

心房颤动脉冲场消融术后临床结局的性别差异

Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation.
PubMed 文献 · JAMA Cardiol · 2023-01-01

本研究基于MANIFEST-PF多国注册研究,回顾性分析1568例首次接受脉冲场消融(PFA)的心房颤动患者,比较男女临床结局。

要点

  • 女性患者年龄更大、阵发性房颤更多,但冠心病、心衰等合并症更少。

核心结论

  • PFA治疗房颤后临床有效性和安全性无显著性别差异。

研究设计与样本

  • 回顾性队列研究,基于MANIFEST-PF多国注册研究,纳入24个欧洲中心连续患者。
  • 共纳入1568例(女性553例,男性1015例)首次接受PFA的房颤患者,中位随访1年。

临床怎么用

  • PFA用于房颤消融时,性别不应作为疗效或安全性差异的顾虑依据。

局限性

  • 回顾性注册研究设计可能引入选择偏倚和残余混杂。
  • 随访时间中位仅1年,缺乏长期结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Previous studies evaluating the association of patient sex with clinical outcomes using conventional thermal ablative modalities for atrial fibrillation (AF) such as radiofrequency or cryoablation are controversial due to mixed results. Pulsed field ablation (PFA) is a novel AF ablation energy modality that has demonstrated preferential myocardial tissue ablation with a unique safety profile. OBJECTIVE: To compare sex differences in patients undergoing PFA for AF in the Multinational Survey on the Methods, Efficacy, and Safety on the Postapproval Clinical Use of Pulsed Field Ablation (MANIFEST-PF) registry. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study of MANIFEST-PF registry data, which included consecutive patients undergoing postregulatory approval treatment with PFA to treat AF between March 2021 and May 2022 with a median follow-up of 1 year. MANIFEST-PF is a multinational, retrospectively analyzed, prospectively enrolled patient-level registry including 24 European centers. The study included all consecutive registry patients (age ≥18 years) who underwent first-ever PFA for paroxysmal or persistent AF. EXPOSURE: PFA was performed on patients with AF. All patients underwent pulmonary vein isolation and additional ablation, which was performed at the discretion of the operator. MAIN OUTCOMES AND MEASURES: The primary effectiveness outcome was freedom from clinically documented atrial arrhythmia for 30 seconds or longer after a 3-month blanking period. The primary safety outcome was the composite of acute (<7 days postprocedure) and chronic (>7 days) major adverse events (MAEs). RESULTS: Of 1568 patients (mean [SD] age, 64.5 [11.5] years; 1015 male [64.7%]) with AF who underwent PFA, female patients, as compared with male patients, were older (mean [SD] age, 68 [10] years vs 62 [12] years; P < .001), had more paroxysmal AF (70.2% [388 of 553] vs 62.4% [633 of 1015]; P = .002) but had fewer comorbidities such as coronary disease (9% [38 of 553] vs 15.9% [129 of 1015]; P < .001), heart failure (10.5% [58 of 553] vs 16.6% [168 of 1015]; P = .001), and sleep apnea (4.7% [18 of 553] vs 11.7% [84 of 1015]; P < .001). Pulmonary vein isolation was performed in 99.8% of female (552 of 553) and 98.9% of male (1004 of 1015; P = .90) patients. Additional ablation was performed in 22.4% of female (124 of 553) and 23.1% of male (235 of 1015; P = .79) patients. The 1-year Kaplan-Meier estimate for freedom from atrial arrhythmia was similar in male and female patients (79.0%; 95% CI, 76.3%-81.5% vs 76.3%; 95% CI, 72.5%-79.8%; P = .28). There was also no significant difference in acute major AEs between groups (male, 1.5% [16 of 1015] vs female, 2.5% [14 of 553]; P = .19). CONCLUSION AND RELEVANCE: Results of this cohort study suggest that after PFA for AF, there were no significant sex differences in clinical effectiveness or safety events.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Turagam MK, Neuzil P, Schmidt B, et al. Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation. JAMA Cardiol. 2023. PMID: 37910101. doi:10.1001/jamacardio.2023.3752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。